DRGEM Corporation (KOSDAQ:263690)
5,110.00
+110.00 (2.20%)
At close: Jul 10, 2026
DRGEM Market Cap
DRGEM has a market cap or net worth of 55.68 billion as of July 10, 2026. Its market cap has decreased by -7.26% in one year.
Market Cap
55.68B
Enterprise Value
47.51B
Revenue
106.74B
Ranking
n/a
PE Ratio
5.80
Stock Price
5,110.00
Market Cap Chart
Since November 22, 2018, DRGEM's market cap has decreased from 76.56B to 55.68B, a decrease of -27.28%. That is a compound annual growth rate of -4.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 55.68B | -4.31% |
| Dec 30, 2025 | 58.18B | -6.54% |
| Dec 30, 2024 | 62.26B | -45.72% |
| Dec 28, 2023 | 114.68B | -1.79% |
| Dec 29, 2022 | 116.78B | -13.05% |
| Dec 30, 2021 | 134.30B | -29.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| L&K Biomed | 104.83B |
| Remed | 85.46B |
| SELVAS Healthcare | 69.44B |
| Hironic | 60.47B |
| Dynamic solution | 55.06B |
| QuantaMatrix | 45.91B |
| Genoray | 42.27B |
| JPI Healthcare | 36.81B |